DarioHealth
DRIO
37 hedge funds and large institutions have $9.75M invested in DarioHealth in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 18 reducing their positions, and 1 closing their positions.
1,575% more call options, than puts
Call options by funds: $67K | Put options by funds: $4K
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
6% more funds holding
Funds holding: 35 → 37 (+2)
0.28% less ownership
Funds ownership: 1.65% → 1.37% (-0.28%)
29% less capital invested
Capital invested by funds: $13.7M → $9.75M (-$3.98M)
72% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$102K |
| 2 |
DIM
DLK Investment Management
Solana Beach,
California
|
+$83K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$80.4K |
| 4 |
AWAM
Appian Way Asset Management
New York
|
+$59.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$54.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$342K |
| 2 |
YDMI
Y.D. More Investments
Ramat Gan,
Israel
|
-$314K |
| 3 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
-$264K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$177K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$175K |
DRIO Hedge Fund Activity: Q2 2024 in Review
37 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q2 2024, worth a combined $9.75M — down 29% from $13.7M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new DRIO positions and 1 closed out — a net gain of 3 holders — while 5 added to existing stakes and 18 trimmed.
The largest buyer was UBS Group, adding an estimated $102K. The largest seller was Nantahala Capital Management, cutting an estimated $342K.
- 37 institutional investors held DarioHealth (DRIO) as of Q2 2024, up from 35 in Q1 2024.
- Funds reported $9.75M of DarioHealth stock for Q2 2024, down 29% quarter-over-quarter.
- 4 funds opened new DarioHealth positions in Q2 2024 and 1 closed out, a net change of +3 holders.
- The largest DarioHealth buyer in Q2 2024 was UBS Group, an estimated $102K added.
- The largest DarioHealth seller in Q2 2024 was Nantahala Capital Management, an estimated $342K sold.
Based on aggregated 13F filings for Q2 2024.